NanoBio Awarded Seventh U.S. Patent
ANN ARBOR ? NanoBio Corporation announced Tuesday that it has been awarded a seventh U.S. patent covering its novel nanoemulsion technology. The new claims encompass methods of treating Herpes Simplex I infections, including herpes labialis (commonly referred to as cold sores), using NanoBio's proprietary anti-infective nanoemulsion product candidates. This new patent covers NanoBio?s NB-001, a